Resources

Functional and Structural Brain Alterations in Encephalitis With LGI1 Antibodies February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7146067/

Learn more
Autoantibodies to the N-Methyl-D-Aspartate Receptor in Adolescents With Early Onset Psychosis and Healthy Contro February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381144/

Learn more
Immune-Checkpoint-Inhibitor-Induced Severe Autoimmune Encephalitis Treated by Steroid and Intravenous Immunoglobulin February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444136/

Learn more
Evaluation of seizure treatment in anti-LGI1, anti-NMDAR, and anti-GABABR encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6537134/

Learn more
Editorial: Emerging Challenges in the Diagnosis and Treatment of Autoimmune Encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398345/

Learn more
Editorial: Recent Advances in Psychiatry From Psycho-Neuro-Immunology Research: Autoimmune Encephalitis, Autoimmune Encephalopathy, and Mild Encephalitis February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6455066/

Learn more
Autoimmune seizures and epilepsy February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6391086/

Learn more
The expanded clinical spectrum of anti-GABABR encephalitis and added value of KCTD16 autoantibodies February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536844/

Learn more
Effect of Clozapine on Anti-N-Methyl-D-Aspartate Receptor Encephalitis With Psychiatric Symptoms: A Series of Three Cases February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6465601/

Learn more
Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitors February 27, 2021

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6705619/

Learn more